Table 3 Human resources needs and salary costs for initiating all those eligible for antiretroviral therapy (ART) and maintaining them on ART for one year, under different treatment strategies
Human resources needs | Costs | |||||||
|---|---|---|---|---|---|---|---|---|
Nurse- months × 1,000 (95% CI) | Nurse FTEs × 1,000 (95% CI) | Counselor months × 1,000 (95% CI) | Counselor FTEs × 1,000 (95% CI) | Doctor- months × 1,000 (95% CI) | Doctor FTEs × 1,000 (95% CI) | Total salary costs, in million ZAR) (95% CI) | Proportion of current HIV sector budget, % (95% CI)a | |
Point estimate b | ||||||||
CD4 ≤200 | 12 (8 to 16) | 1.0 (0.7 to 1.3) | 20 (12 to 28) | 1.7 (1.0 to 2.3) | 2 (1 to 2) | 0.1 (0.1 to 0.2) | 12 (8 to 16) | 12 (8 to 16) |
CD4 ≤350 (TB or pregnant); CD4 ≤200 (all other HIV-infected people) | 15 (10 to 20) | 1.3 (0.9 to 1.7) | 27 (16 to 37) | 2.2 (1.4 to 3.1) | 2 (1 to 3) | 0.2 (0.1 to 0.2) | 15 (10 to 20) | 15 (10 to 20) |
CD4 ≤350 | 26 (18 to 35) | 2.2 (1.5 to 2.9) | 45 (28 to 63) | 3.8 (2.3 to 5.2) | 3 (2 to 4) | 0.3 (0.2 to 0.4) | 26 (18 to 35) | 26 (18 to 35) |
CD4 ≤500 | 51 (34 to67) | 4.2 (2.8 to 5.6) | 87 (53 to 121) | 7.3 (4.4 to 10.1) | 6 (5 to 8) | 0.5 (0.4 to 0.7) | 51 (34 to67) | 51 (34 to67) |
All HIV-positive people | 74 (50 to 99) | 6.2 (4.2 to 8.2) | 129 (79 to 179) | 10.7 (6.6 to 14.9) | 9 (7 to 12) | 0.8 (0.6 to 1.0) | 74 (50 to 99) | 74 (50 to 99) |
High estimate b | ||||||||
CD4 ≤200 | 17 (11 to 22) | 1.4 (0.9 to 1.8) | 29 (17 to 40) | 2.4 (1.5 to 3.3) | 2 (1 to 3) | 0.2 (0.1 to 0.2) | 17 (11 to 22) | 17 (11 to 22) |
CD4 ≤350 (TB or pregnant); CD4 ≤200 (all other HIV-infected people) | 20 (13 to 26) | 1.6 (1.1 to 2.2) | 34 (21 to 48) | 2.8 (1.7 to 4.0) | 3 (2 to 3) | 0.2 (0.2 to 0.3) | 20 (13 to 26) | 20 (13 to 26) |
CD4 ≤350 | 30 (20 to 39) | 2.5 (1.7 to 3.3) | 51 (31 to 71) | 4.2 (2.6 to 5.9) | 4 (3 to 5) | 0.3 (0.2 to 0.4) | 30 (20 to 39) | 30 (20 to 39) |
CD4 ≤500 | 54 (37 to 72) | 4.5 (3.0 to 6.0) | 94 (57 to 130) | 7.8 (4.8 to 10.9) | 7 (5 to 9) | 0.6 (0.4 to 0.7) | 54 (37 to 72) | 54 (37 to 72) |
All HIV-positive people | 80 (54 to 106) | 6.6 (4.5 to 8.8) | 137 (84 to 191) | 11.4 (7.0 to 15.9) | 10(7 to 13) | 0.8 (0.6 to 1.1) | 80 (54 to 106) | 80 (54 to 106) |
Low estimate b | ||||||||
CD4 ≤200 | 9 (6 to 11) | 0.7 (0.5 to 1.0) | 15 (9 to 20) | 1.2 (0.7 to 1.7) | 1 (1 to 1) | 0.1 (0.1 to 0.1) | 9 (6 to 11) | 9 (6 to 11) |
CD4 ≤350 (TB or pregnant); CD4 ≤200 (all other HIV-infected people) | 13 (8 to 17) | 1.1 (0.7 to 1.4) | 22 (13 to 30) | 1.8 (1.1 to 2.5) | 2 (2 to 3) | 0.1 (0.1 to 0.2) | 13 (8 to 17) | 13 (8 to 17) |
CD4 ≤350 | 25 (17 to 33) | 2.1 (1.4 to 2.7) | 43 (26 to 59) | 3.5 (2.2 to 4.9) | 3 (2 to 4) | 0.3 (0.2 to 0.3) | 25 (17 to 33) | 25 (17 to 33) |
CD4 ≤500 | 48 (32 to 64) | 4.0 (2.7 to 5.3) | 83 (51 to 115) | 6.9 (4.2 to 9.6) | 6 (4 to 8) | 0.5 (0.4 to 0.7) | 48 (32 to 64) | 48 (32 to 64) |
All HIV-positive people | 72 (48 to 95) | 6.0 (4.0 to 7.9) | 123 (75 to 171) | 10.3 (6.2 to 14.3) | 9 (6 to 12) | 0.8 (0.5 to 1.0) | 72 (48 to 95) | 72 (48 to 95) |